683a163cc782e11e38d1b2b0
10218
ATLAS Score for Clostridium Difficile Infection
ATLAS Score for Clostridium Difficile Infection
ATLAS Score for C. Diff. Colitis
Predicts response to therapy in patients with C. diff.
C. diff therapy response.
atlas-score-clostridium-difficile-infection
The ATLAS Score for Clostridium Difficile Infection predicts response to therapy in patients with C. diff.
Atlas, c. diff. Colitis, c diff, c diff Colitis, atlas score, Clostridium Difficile Infection
[ "Abdominal Pain", "Diarrhea", "Fever" ]
Addition of the selected points: *Note: the original validation (Miller 2013) examined 6 parameters: age, temperature, leukocyte count, albumin, serum creatinine, and systemic antibiotics. The combination of parameters which led to the greatest discrimination among risk groups and correlation with cure was the five excluding temperature, and MDCalc uses this version for that reason.
[]
Interpretation:
|
ATLAS Score |
Cure rate |
Mortality |
|
0 |
95.7% |
0.0% |
|
1 |
93.3% |
0.0% |
|
2 |
92.7% |
0.0% |
|
3 |
89.5% |
3.6% |
|
4 |
81.1% |
4.2% |
|
5 |
76.1% |
8.7% |
|
6 |
85.7% |
10.9% |
|
7 |
50.0% |
14.3% |
|
8 |
55.6% |
56.0% |
|
9 |
33.0% |
>56.0% |
|
10 |
<33.0% |
Cure rate from Miller 2013 and mortality from Miller 2010.
{ "Clinical Practice Guidelines": [ { "href": "", "text": "" } ], "Manufacturer Website": [ { "href": "", "text": "" } ], "Original/Primary Reference": [ { "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-13-148", "text": "Miller MA, Louie T, Mullane K, et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infect Dis. 2013;13:148." } ], "Other References": [ { "href": "https://idsa.confex.com/idsa/2010/webprogram/Paper4263.html", "text": "Miller MA. ATLAS - A Bedside Scoring System Predicting Mortality Due to Clostridium Difficile Infection (CDI) in Elderly Hospitalized Patients. 48th IDSA Annual Meeting. 2010;P452." }, { "href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265469/ ", "text": "Abou Chakra CN, Pepin J, Valiquette L. Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review. PLoS ONE. 2012;7(1):e30258." }, { "href": "https://www.sciencedirect.com/science/article/pii/S1413867015001063", "text": "Hernández-García R, Garza-González E, Miller M, Arteaga-Muller G, Galván-De Los Santos AM, Camacho-Ortiz A. Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico. Braz J Infect Dis. 2015;19(4):399-402." }, { "href": "https://jamanetwork.com/journals/jama/article-abstract/2091993 ", "text": "Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398-408." } ], "Outcomes": [ { "href": "", "text": "" } ], "Validation": [ { "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-13-148", "text": "Miller MA, Louie T, Mullane K, et al. Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infect Dis. 2013;13:148." } ], "Validations": [] }
Use in patients diagnosed with C. difficile infection (CDI) at the time of diagnosis to stratify disease severity.
Useful for identifying patients with CDI who are at high risk for severe outcomes or mortality. Determining disease severity can aid in clinical decision-making for treatment intensity and level of care (e.g., outpatient versus inpatient management). Results can assist in discussions with patients and families about prognosis and treatment options.
For detailed treatment recommendations, please refer to clinical guidelines from the American College of Gastroenterology, the American Society of Colon and Rectal Surgeons, and the Infectious Disease Society of America/Society for Healthcare Epidemiology of America.
[ "Sepsis" ]
{ "conditionality": "", "default": 0, "label_en": "<p><span style=\"text-decoration: underline;\"><strong>A</strong></span>ge, years</p>", "mdcalc_info_concept": null, "name": "age", "option_fhir_rules": null, "optional": false, "options": [ { "label": "<60", "value": 0 }, { "label": "60-79", "value": 1 }, { "label": "≥80", "value": 2 } ], "show_points": true, "tips_en": "", "type": "radio" }
{ "conditionality": "", "default": 0, "label_en": "<p><strong><span style=\"text-decoration: underline;\">T</span></strong>reatment with systemic antibiotics during C. diff infection therapy</p>", "md_calc_info_concept": null, "name": "treat", "option_fhir_rules": null, "optional": false, "options": [ { "label": "No", "value": 0 }, { "label": "Yes", "value": 2 } ], "show_points": true, "tips_en": "≥1 day duration", "type": "toggle" }
{ "conditionality": "", "default": 0, "label_en": "<p><span style=\"text-decoration: underline;\"><strong>L</strong></span>eukocyte count, cells/µL</p>", "mdcalc_info_concept": null, "name": "leuk", "option_fhir_rules": null, "optional": false, "options": [ { "label": "<16,000", "value": 0 }, { "label": "16,000-25,000", "value": 1 }, { "label": ">25,000", "value": 2 } ], "show_points": true, "tips_en": "", "type": "radio" }
{ "conditionality": "", "default": 0, "label_en": "<p>Serum <strong><span style=\"text-decoration: underline;\">a</span></strong>lbumin</p>", "mdcalc_info_concept": null, "name": "alb", "option_fhir_rules": null, "optional": false, "options": [ { "label": ">3.5 g/dL (>35 g/L)", "value": 0 }, { "label": "2.6-3.5 g/dL (26-35 g/L)", "value": 1 }, { "label": "<2.6 g/dL (<26 g/L)", "value": 2 } ], "show_points": true, "tips_en": "", "type": "radio" }
{ "conditionality": "", "default": 0, "label_en": "<p><span style=\"text-decoration: underline;\"><strong>S</strong></span>erum creatinine</p>", "mdcalc_info_concept": null, "name": "cr", "option_fhir_rules": null, "optional": false, "options": [ { "label": "≤1.3 mg/dL (≤120 μmol/L)", "value": 0 }, { "label": "1.4-2.0 mg/dL (121-179 μmol/L)", "value": 1 }, { "label": "≥2.1 mg/dL (≥180 μmol/L)", "value": 2 } ], "show_points": true, "tips_en": "As a measure of renal function", "type": "radio" }
[ { "conditionality": "", "default": 0, "label_en": "<p><span style=\"text-decoration: underline;\"><strong>A</strong></span>ge, years</p>", "mdcalc_info_concept": null, "name": "age", "option_fhir_rules": null, "optional": false, "options": [ { "label": "<60", "value": 0 }, { "label": "60-79", "value": 1 }, { "label": "≥80", "value": 2 } ], "show_points": true, "tips_en": "", "type": "radio" }, { "conditionality": "", "default": 0, "label_en": "<p><strong><span style=\"text-decoration: underline;\">T</span></strong>reatment with systemic antibiotics during C. diff infection therapy</p>", "md_calc_info_concept": null, "name": "treat", "option_fhir_rules": null, "optional": false, "options": [ { "label": "No", "value": 0 }, { "label": "Yes", "value": 2 } ], "show_points": true, "tips_en": "≥1 day duration", "type": "toggle" }, { "conditionality": "", "default": 0, "label_en": "<p><span style=\"text-decoration: underline;\"><strong>L</strong></span>eukocyte count, cells/µL</p>", "mdcalc_info_concept": null, "name": "leuk", "option_fhir_rules": null, "optional": false, "options": [ { "label": "<16,000", "value": 0 }, { "label": "16,000-25,000", "value": 1 }, { "label": ">25,000", "value": 2 } ], "show_points": true, "tips_en": "", "type": "radio" }, { "conditionality": "", "default": 0, "label_en": "<p>Serum <strong><span style=\"text-decoration: underline;\">a</span></strong>lbumin</p>", "mdcalc_info_concept": null, "name": "alb", "option_fhir_rules": null, "optional": false, "options": [ { "label": ">3.5 g/dL (>35 g/L)", "value": 0 }, { "label": "2.6-3.5 g/dL (26-35 g/L)", "value": 1 }, { "label": "<2.6 g/dL (<26 g/L)", "value": 2 } ], "show_points": true, "tips_en": "", "type": "radio" }, { "conditionality": "", "default": 0, "label_en": "<p><span style=\"text-decoration: underline;\"><strong>S</strong></span>erum creatinine</p>", "mdcalc_info_concept": null, "name": "cr", "option_fhir_rules": null, "optional": false, "options": [ { "label": "≤1.3 mg/dL (≤120 μmol/L)", "value": 0 }, { "label": "1.4-2.0 mg/dL (121-179 μmol/L)", "value": 1 }, { "label": "≥2.1 mg/dL (≥180 μmol/L)", "value": 2 } ], "show_points": true, "tips_en": "As a measure of renal function", "type": "radio" } ]
2022-04-21T20:28:35.864Z
[ "Prognosis" ]
[ "Atlas", "c. diff. Colitis", "c diff", "c diff Colitis", "atlas score", "Clostridium Difficile Infection" ]
{ "keywords_en": "Atlas, c. diff. Colitis, c diff, c diff Colitis, atlas score, Clostridium Difficile Infection", "meta_description_en": "The ATLAS Score for Clostridium Difficile Infection predicts response to therapy in patients with C. diff." }
[ "Family Practice", "Gastroenterology", "Hospitalist Medicine", "Internal Medicine", "Primary Care" ]
[ "Gastrointestinal", "Infectious" ]
[]
1
[]
[ { "calcId": 10512, "short_title_en": "Travis Criteria", "slug": "travis-criteria" }, { "calcId": 10511, "short_title_en": "Ho Index", "slug": "ho-index" }, { "calcId": 10519, "short_title_en": "Menza Score", "slug": "menza-score" } ]
false
[ "whenToUseViewed", "pearlsPitfallsViewed", "whyUseViewed", "nextStepsViewed", "evidenceViewed" ]
[ "gastroenterology", "infectious" ]
[ "Use in patients diagnosed withC. difficileinfection (CDI) at the time of diagnosis to stratify disease severity." ]
false